Lab Gabriele Bergers
Home
Laboratory of Tumor Microenvironment and Therapeutic Resistance
The long-term goal of our lab is to conduct a comprehensive investigation that defines the dialogues of heterogeneous tumor cell subtypes, and the vasculature and immune cells in the distinct tumor vascular niches in response during progression as well as targeted therapies including antiangiogenic and immune-modulating therapies.
Gabriele Bergers
VIB Group Leader, August 2016-present
Professor in the Department of Oncology, KU Leuven, Belgium
Adjunct Professor, University of California, San Francisco, USA, 2016-2021
Full Professor,: University of California, San Francisco, USA, 2010-2016
Assistant/Associate Professor: Univ. of California, San Francisco, USA, 2001-2005/2005-2010
Research Scientist: Univ. of California, San Francisco, USA, 1994-2001
Research focus
Publications
Expertise
Team
News
We're supported by
Understanding and influencing the tumor microenvironment
For a long time, cancer research was all about investigating the genetic traits of cancer cells. But in the past couple of decades, it gradually dawned on researchers that the key to more effective cancer therapies might lie in the complex structures surrounding these cancer cells. VIB scientists have been investigating the tumor microenvironment for many years, and have discovered multiple ways to fight tumors, including starving them to death, "stealing" their sugar supply, and boosting their destruction using immunotherapy.